News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Daily News ACC: It’s Time for Clinicians to Address Inflammation in CVD Caitlin E. Cox October 03, 2025
News Conference News ESC 2025 DAPT’s Role After CABG Questioned: TACSI and TOP-CABG Caitlin E. Cox September 05, 2025
News Conference News ESC 2025 No Benefit to Routine CT Angiography After Left Main PCI: PULSE Michael O'Riordan August 31, 2025
News Daily News DAPT De-escalation Success Varies by Sex: Meta-analysis Yael L. Maxwell August 21, 2025
News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025
News Conference News EuroPCR 2025 ‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI Michael O'Riordan May 29, 2025
News Conference News EuroPCR 2025 Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT Yael L. Maxwell May 23, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab Michael O'Riordan February 05, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025